Le Lézard
Classified in: Health, Science and technology

Vincari's Surgical CAPD Makes Accurate Reimbursement Possible by Making Accurate Surgical Documentation Simple


BIRMINGHAM, Ala., Dec. 15, 2017 /PRNewswire/ -- Vincari's On the Go Surgical Computer Assisted Physician Documentation (CAPD) solution takes the painful process of surgical documentation and makes it simple for them to provide the information downstream care and coding teams need.  Vincari was created by a practicing general surgeon nearly a decade ago because he recognized the amount of money being left on the table due to incomplete documentation and knew that there must be a better solution than traditional methods of gathering accurate information.

Vincari's Lightspeed Valet is the only ICD-10 virtual assistant designed by surgeons for surgeons to complete operative reports with 100% Joint Commission compliance and ICD-10 specific language. (PRNewsFoto/Vincari)

Why is accurate documentation so critical?  The shift to value-based care is increasing the pressure to deliver timely, accurate, and compliant surgical documentation.  In order to receive appropriate reimbursement, surgeons must be able to prove through documentation the level of care provided.  In the eyes of payers, if it's not documented, it didn't happen.

What's the difference in Vincari and other traditional documentation methods?  The rules around surgical documentation are constantly evolving. Vincari takes a rule-based, point-of-care approach which adapts to assist physicians with the capture of accurate surgical information.  Other methods require surgeons to re-educate themselves on the changing documentation requirements as edits are made, and remember these differences when dictating.   In a nutshell, Vincari turns an "essay" test where even the questions are unknown into a multiple-choice test with clear requirements and options.   

"Our hospital understands the needs of physicians and the critical balance of time spent between patients and documentation. We've chosen Vincari to provide our physicians an exceptional product to make documentation and coding of ICD-10 easy and effortless. Vincari gives physicians the time to be physicians."  William Mahone, President of Halifax Regional, Novant Health

Visit Vincari.com to learn more about our Surgical CAPD solution and how it can help your facility capture accurate documentation to realize accurate reimbursement.  

About Vincari
Headquartered in Birmingham, AL, Vincari is the Electronic Physician Assistant designed to improve the way patient information is captured, leveraged, and delivered. Vincari's rules-based, point of care physician workflows help capture the complete picture of patient encounters from the office, bedside, or surgery suite. By leveraging learned physician behavior and existing clinical information, Vincari improves workflow efficiency and streamlines the documentation and coding process. As a result, clinical documentation and charge capture data is delivered immediately to office and hospital EMRs, all while logging case data for research, recertification, and analytical purposes.

 

SOURCE Vincari


These press releases may also interest you

at 07:45
Sensi.AI, a leader in AI-native, data, and analytics in senior care, today announced the appointment of in-home care leader Bob Roth to its Advisory Board. This partnership is an exciting validation of Sensi.AI's promise to enhance proactive,...

at 07:05
Three major challenges poised to confront the nation's clinical laboratories, genetic test companies, and anatomic pathology laboratories will be major topics when a top-flight roster of lab experts, innovators, and lab leaders gather in New Orleans...

at 07:05
Surmodics, Inc. , a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that second quarter of fiscal year 2024 financial results will be released before the market opens on Wednesday,...

at 07:04
Merck , known as MSD outside the United States and Canada, announced that Health Canada has granted approval of  KEYTRUDA® (pembrolizumab), Merck's anti-PD-1 therapy, in combination with fluoropyrimidine- and platinum-containing-chemotherapy, for the...

at 07:00
Globe Life Inc. will release First Quarter 2024 earnings after the market closes on Monday, April 22, 2024.  At that time, a copy of the Company's First Quarter 2024 earnings press release and any other financial and statistical information about...

at 07:00
GenFleet Therapeutics, a clinical-stage biotechnology company focusing on cutting-edge therapies in oncology and immunology, announced US Food and Drug Administration (FDA) has granted the clinical trial approval for GFH925 (KRAS G12C inhibitor) in a...



News published on and distributed by: